drugset / Trial / NCT02127320

Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

NCT02127320

Phase 1 Completed 24 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the pharmacokinetic drug interactions between Rosuvastatin and Ezetimibe in Healthy Male Subjects

Timeline

Start
2014-06
Primary completion
2014-09
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg
Subject Rosuvastatin Small molecule 20 mg

Indications

No indication recorded.